Philadelphia Chromosome-positive Chronic Myeloid Leukemia

• FDA approval · 2025-08-25
  FDA Approved: DASATINIB — Original Application (Lupin Pharmaceuticals, Inc.)

  FDA approves Lupin Pharmaceuticals' generic dasatinib (original ANDA) for the treatment of Philadelphia chromosome-positive chronic myeloid …

• CLINICAL_TRIALS trial_result · 2021-12-30
  Clinical Trial Update: Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors [Phase 4]

  Phase 4 safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients previously treated with…

• FDA approval · 2015-01-26
  FDA Approved: DASATINIB — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for dasatinib by Prasco Laboratories, enabling the marketing of a generic version. The drug is indic…